Your browser doesn't support javascript.
loading
Isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma patients with high-risk cytogenetics: IKEMA subgroup analysis.
Spicka, Ivan; Moreau, Philippe; Martin, Thomas G; Facon, Thierry; Martinez, Gracia; Oriol, Albert; Koh, Youngil; Lim, Andrew; Mikala, Gabor; Rosiñol, Laura; Yagci, Münci; Cavo, Michele; Risse, Marie-Laure; Asset, Gaëlle; Macé, Sandrine; van de Velde, Helgi; Yong, Kwee.
Afiliación
  • Spicka I; 1st Department of Medicine-Department of Hematology, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic.
  • Moreau P; University of Nantes, Nantes, France.
  • Martin TG; University of California San Francisco, San Francisco, California, USA.
  • Facon T; Department of Haematology, Lille University Hospital, Lille, France.
  • Martinez G; Hospital das Clínicas de Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Oriol A; Hematology Department, Institut Català d'Oncologia and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Koh Y; Seoul National University Hospital, Seoul, South Korea.
  • Lim A; Austin and Repatriation Medical Center, Heidelberg, Victoria, Australia.
  • Mikala G; Department of Hematology and Stem Cell Transplantation, National Institute for Hematology and Infectious Diseases, South Pest Central Hospital, Budapest, Hungary.
  • Rosiñol L; Hospital Clinic, IDIBAPS, Barcelona, Spain.
  • Yagci M; Gazi University, Ankara, Turkey.
  • Cavo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
  • Risse ML; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
  • Asset G; Sanofi, R&D, Vitry-Sur-Seine, France.
  • Macé S; Sanofi, R&D, Chilly-Mazarin, France.
  • van de Velde H; Sanofi, R&D, Vitry-Sur-Seine, France.
  • Yong K; Sanofi, Cambridge, Massachusetts, USA.
Eur J Haematol ; 109(5): 504-512, 2022 Nov.
Article en En | MEDLINE | ID: mdl-35871357

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: República Checa

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: República Checa